Further to PAH, it was found that, in animals with cardiac hypertrophy and cardiac failure (caused by transverse narrowing of the aorta), rapamycin weakens cardiac dysfunction and remodeling by suppressing mTOR. The gene discussed is MTOR; the disease is pulmonary arterial hypertension.